Salesforce (CRM)
(Delayed Data from NYSE)
$274.29 USD
+1.15 (0.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $274.49 +0.20 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$274.29 USD
+1.15 (0.42%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $274.49 +0.20 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Zacks News
BOX Bolsters Box Sign Portfolio With FDA Part 11 Approval
by Zacks Equity Research
BOX receives FDA 21 CFR Part 11 approval for electronic signatures, facilitating research, development and manufacturing processes without incurring incremental costs.
Salesforce Inc. (CRM) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce (CRM) Unveils GenAI-Powered Tools for Retailers
by Zacks Equity Research
Salesforce (CRM) brings generative AI to its Commerce Cloud and Marketing Cloud solutions, which is likely to help retail merchandisers optimize their business operations while enhancing shoppers' experience.
Salesforce.com (CRM) Exceeds Market Returns: Some Facts to Consider
by Zacks Equity Research
The latest trading day saw Salesforce.com (CRM) settling at $271.93, representing a +0.2% change from its previous close.
Adobe (ADBE) Up 2.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Adobe (ADBE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Infosys (INFY) Gains 4% as Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Infosys' (INFY) better-than-expected Q3 performance reflects the benefits of strong sales executions and improved operational efficiencies.
Amazon (AMZN) Teams Up With Salesforce to Boost Prime Momentum
by Zacks Equity Research
Amazon (AMZN) partners with Salesforce to integrate Buy with Prime into the latter's Commerce Cloud platform.
Bridgeline (BLIN) Strengthens Portfolio With HawkSearch Launch
by Zacks Equity Research
Bridgeline's (BLIN) HawkSearch AI unveils Smart Search, transforming e-commerce with advanced AI for precise, image-enhanced searches.
The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group
by Zacks Equity Research
Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.
Top Analyst Reports for Merck, Salesforce & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
Wall Street Analysts Think Salesforce.com (CRM) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Salesforce.com (CRM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Salesforce Inc. (CRM) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Salesforce.com (CRM) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Salesforce.com (CRM) Up 5.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Salesforce.com (CRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Automatic Data (ADP) Deserves to be Retained Now
by Zacks Equity Research
Automatic Data (ADP) grows through strategic acquisitions and partnerships. Partnerships with Workday and Salesforce elevate HR interactions.
Investors Heavily Search Salesforce Inc. (CRM): Here is What You Need to Know
by Zacks Equity Research
Salesforce.com (CRM) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's How Much a $1000 Investment in Salesforce.com Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Why Salesforce.com (CRM) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Analyst Blog Highlights Salesforce, Intel, Microsoft, Apple and Boeing
by Zacks Equity Research
Salesforce, Intel, Microsoft, Apple and Boeing are part of the Zacks top Analyst Blog.
Salesforce (CRM) Boosts AI Offerings With Einstein 1 Upgrades
by Zacks Equity Research
Salesforce's (CRM) groundbreaking updates - the Data Cloud Vector Database and Einstein Copilot Search - signify a transformative shift in AI capabilities, propelling customer-centricity and operational efficiency to new heights.
5 Winning Stocks of 2023 as Dow Jones Hits New Record
by Sweta Killa
The Dow Jones hits a new record, surpassing 37,000 for the first time. Salesforce (CRM), Intel (INTC), Microsoft (MSFT), Apple (AAPL) and Boeing (BA) emerge as the biggest winners of 2023.
Salesforce (CRM) & ADP Tie Up to Enhance Client Experience
by Zacks Equity Research
Salesforce (CRM) and Automatic Data Processing are set to transform client experience by integrating generative artificial intelligence into human capital management.
5 Stocks Powering Dow ETF's 3-Month Outperformance
by Sweta Killa
The Dow Jones has been outperforming over the past three months, rising 5.8% compared with a 3.9% increase for the S&P 500.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stock Market News for Dec 13, 2023
by Zacks Equity Research
Wall Street closed higher on Tuesday as market participants gauged key inflation data and expected the Federal Reserve to keep interest rates unchanged for the third consecutive time.
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.